HOME >> MEDICINE >> NEWS
Elements of green tea prevent HIV from binding to human T cells

The major component of green tea prevents the binding of HIV to human T cells, the first step in HIV infection, according to a study and an accompanying editorial published in the November 2003 Journal of Allergy and Clinical Immunology (JACI). The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).

Green tea is the nonoxidized, unfermented product of the leaves from the evergreen plant, Camellia sinensis. It is made up of catechins, the most abundant of which is Epigallocatechin Gallate (EGCG). It is believed that EGCG is responsible for the vast array of presumed health benefits green tea possesses, such as the prevention of cancer and cardiovascular disease. Several studies have reported that EGCG may also have a protective effect against HIV infection.

Kuzushige Kawai, MD, and colleagues from the University of Tokyo demonstrated in laboratory studies that EGCG blocked the binding of HIV envelope glycoprotein to human CD4 molecules on human T cells. The CD4 molecule acts as a binding target for HIV vesicles and plays an important role in the aggressive infection process.

Researchers found that EGCG showed a strong affinity for the CD4 molecule, and by binding them, could effectively prevent the binding of the HIV glycoprotein envelope. These findings open new doors for the clinical application of EGCG as a new anti-HIV drug.

Further research into the potential preventative effects of the green tea catechin EGCG on HIV infection is being conducted by researchers at the National Center for Macromolecular Imaging at Baylor College of Medicine, Houston, Texas, and the Department of Molecular Biology and Biotechnology at the University of Sheffield, Sheffield, England. In an editorial accompanying the Kawai study, William T. Shearer, MD, PhD, FAAAAI, and colleagues from Baylor report on the use of advanced computer programs to better define the nature and power of the binding effects of
'"/>

Contact: John Gardner
jgardner@aaaai.org
414-272-6071
American Academy of Allergy, Asthma & Immunology
10-Nov-2003


Page: 1 2

Related medicine news :

1. Charcoal and forest management could reduce greenhouse gas levels & save lives in Africa
2. Component of green tea protects injured livers in mice
3. ESA gives green light to funding for GMES
4. Antioxidant component of green tea blocks new but not established arterial plaque in mice
5. Mayo Clinic researchers discover green tea component helps kill leukemia cells
6. Laying the foundations for greener living
7. New study shows green algae extract boosts flu vaccine
8. Men, women and the green eyed monster
9. UCLA-led study first to show green tea helps prevent chronic gastritis
10. Not enough evidence that multivitamins prevent infections in the elderly
11. International breast cancer prevention study launches in the United States and Canada

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Elements green tea prevent HIV from binding human cells

(Date:3/5/2015)... Southlake, TX (PRWEB) March 05, 2015 ... an in-office, non-surgical treatment for OB-GYNs and Urogynecologists. ... system, used for non-surgical dermatological application in aesthetics ... pleased to have a non-invasive, in-office procedure, and ... for women who want results without surgery. ThermiVa ...
(Date:3/5/2015)... Building on its commitment to provide ... The Academy of Oncology Nurse & Patient Navigators (AONN+) ... voice ™ (CONQUER ™). , “Cancer has ... and their loved ones each year,” says Pam Rattananont ... ever, there is a need in the oncology space ...
(Date:3/4/2015)... MyCpapStore.com, an online provider of CPAP equipment ... quality products designed to remedy the problem of snoring. ... merchandise from name-brand manufacturers, giving its customers access to ... Sleep apnea is a common condition affecting people of ... restricted airflow. The CPAP (continuous positive airway pressure) machine ...
(Date:3/4/2015)... Vegas, NV (PRWEB) March 04, 2015 In ... as the fight that is the main event. For ... and that fight will be for the UFC Featherweight Championship. ... the brash, often out-spoken native of Ireland, Conor “Notorious” McGregor. ... MGM Grand Garden Arena in Las Vegas, NV. , When ...
(Date:3/4/2015)... Dr. Christopher Asandra, M.D., Founder and Chief ... lamented the FDA’s recent decision to issue a ... that FDA’s conclusions are not supported by science, and ... testosterone deficiency. , “The FDA appears to have developed ... said Dr. Asandra. “There is not nearly enough evidence ...
Breaking Medicine News(10 mins):Health News:ThermiHealth Announces the Introduction of ThermiVa in North America to OB-GYNs 2Health News:ThermiHealth Announces the Introduction of ThermiVa in North America to OB-GYNs 3Health News:The Academy of Oncology Nurse & Patient Navigators Launches CONQUER: the patient voice™ to Help Meet the Informational Needs of Patients with Cancer 2Health News:Sleep Apnea Machines CPAP and BiPap Machines Now Available for Sale 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2
(Date:3/4/2015)... , March 4, 2015  NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank , Chief Executive ... in Miami, FL on Wednesday, March ... webcast of the event will be made available at ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
(Date:3/4/2015)... Texas , March 4, 2015 ... II pilot study in patients with moderate to ... Dermatology. The open-label Phase II trial evaluated the ... monoclonal antibody that targets interleukin-1 alpha (IL-1a). IL-1a ... inflammatory cells present in skin lesions. The Company ...
(Date:3/4/2015)... Pa. , March 4, 2015  Results of ... 100 Consecutive Cases Using MarginProbe for Intra-Operative Positive Margin ... poster session at the 32 nd Annual Miami ... study, conducted by Moshe Papa , MD, FACS, ... at Tel Aviv University, reports an analysis of MarginProbe,s ...
Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2
Cached News: